Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Labcorp Holdings Inc.
LH
NYSE·Healthcare·Medical - Diagnostics & Research·Mkt cap $23.3B
$286.98
▲ +1.09%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$241.81 - $293.72
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 9.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Extensive nationwide laboratory network
- Advanced diagnostic technologies
- Comprehensive healthcare testing capabilities
- Strong relationships with healthcare providers and pharmaceutical companies
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Increasing demand for precision medicine
Value
Fairly valued vs Medical Devices peers
Momentum
Stable
+3.7% over 3m
Quality
Stable
Excellent business quality
Dividend
Modest
1.01% yield
Smart-money signal
Who's buying LH right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Apr 27, 2026
APR 30, 2026
Reported EPS of $4.25 vs $4.09 consensus (+3.9% surprise). Revenue of $3.5B vs $3.5B expected (+0.8%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+3.9%
Next: Apr 27, 2026
Revenue trend · last 8Q
—
—
+10%
+5%
+10%
+9%
+6%
+6%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$3.2B
$3.3B
$3.3B
$3.3B
$3.5B
$3.6B
$3.5B
$3.5B
Margins · last 8Q
Gross
26.5%
Operating
10.9%
Profit
7.8%
Wall Street consensus
4 analysts · 75% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
75%
Hold
25%
Sell
0%
Median Price Target
$317.00
▲ +10.5% vs $286.98
Latest: Baird · $334.00 · May 1, 2026
2 analysts covering
vs Industry
How LH stacks vs Medical - Diagnostics & Research
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related